Self-sterility in Camellia oleifera may be due to the prezygotic late-acting self-incompatibility

PLoS One. 2014 Jun 13;9(6):e99639. doi: 10.1371/journal.pone.0099639. eCollection 2014.

Abstract

In this report, self-sterility in Camellia oleifera was explored by comparing structural and statistical characteristics following self-pollination (SP) and cross-pollination (CP). Although slightly delayed pollen germination and pollen tube growth in selfed ovaries compared to crossed ovaries was observed, there was no significant difference in the percentages of pollen that germinated and pollen tubes that grew to the base of the style. There was also no difference in morphological structure after the two pollination treatments. However, the proportions of ovule penetration and double fertilization in selfed ovules were significantly lower than in crossed ovules, indicating that a prezygotic late-acting self-incompatible mechanism may exist in C. oleifera. Callose deposition was observed in selfed abortive ovules, but not in normal. Ovules did not show differences in anatomic structure during embryonic development, whereas significant differences were observed in the final fruit and seed set. In addition, aborted ovules in selfed ovaries occurred within 35 days after SP and prior to zygote division. However, this process did not occur continuously throughout the life cycle, and no zygotes were observed in the selfed abortive ovules. These results indicated that the self-sterility in C. oleifera may be caused by prezygotic late-acting self-incompatibility (LSI).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Camellia / embryology
  • Camellia / physiology*
  • Crosses, Genetic
  • Germination
  • Plant Infertility*
  • Pollen / growth & development
  • Pollination*

Grants and funding

This study was supported by the National Natural Science Foundation of China (No. 31170639). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.